Nanomedicine · 2019 · 66 citations · 44 references
PharmacyPharmaceuticsPharmacologyDrug DeliveryNanoparticle Drug DeliveryOcular Drug DeliveryCorneal Drug DeliveryLipid-based NanoparticlesNanomaterials For Drug DeliveryOcular NanocarriersOcular Penetration EnhancementOphthalmic FormulationsBioavailability Of Ocular DrugsDrug Delivery To The EyeLipid NanoparticlesNanocarrier CharacterizationNanomaterials For Ocular ApplicationsNanoparticle-based Ophthalmic FormulationsNanoparticle-mediated Ocular PenetrationOcular Toxicity Evaluation
AIM: Evaluation of solid lipid nanoparticles (SLNs) for ocular delivery of isoniazid (INH). MATERIALS & METHODS: INH-SLNs were characterized for morphological, thermal, crystalline and nuclear magnetic resonance properties. In vitro release and ex vivo corneal permeability of INH-SLNs was also evaluated. Proof-of-concept uptake studies were performed in corneal and conjunctival cell lines and in vivo in rat eye using fluorescein-labeled SLNs. Antimycobacterial activity of INH-SLNs was confirmed. In vivo aqueous humor pharmacokinetics, toxicity and tolerance was performed in rabbit/rat eye. RESULTS: INH-SLNs showed extended release (48 h), enhanced corneal permeability (1.6-times), five-times lower MIC, significant in vitro and in vivo uptake of fluorescein-labeled SLNs, 4.2-times ocular bioavailability (area under the curve) and in vivo acute and repeat dose safety. CONCLUSION: INH-SLNs are an effective ocular delivery system.
44
Global tuberculosis report (2014)
L.A. Gabbasova, E.R. Experts Who · 2014 · 13.2K citations
Nanoparticulate systems for brain delivery of drugs
Advanced Drug Delivery Reviews · 2001 · 1K citations
Nanoparticulate systems for brain delivery of drugs
Jörg Kreuter · Advanced Drug Delivery Reviews · 2012 · 958 citations